(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-MZPRZ3M');

IP51/3 – Minimally invasive radical hysterectomy for early stage cervical cancer guidance

30 March 2020

Due to the operational challenges that the COVID-19 pandemic is posing to the NICE normal work programmes, NICE has announced that it is currently reviewing all guidance in development and will only be prioritising therapeutically-critical topics, or those relating to diagnosing or treating COVID-19.   IP51/3 – Minimally invasive radical hysterectomy for early stage cervical cancer guidance is now on hold.

For more information click here

Latest News